Finance

Beta
Lists
2395:TYO
Shin Nippon Biomedical Laboratories Ltd
Â¥1,275.00
+3.07%
(+38.00) 1D
Jul 10, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 2395...
Open
Â¥1,255
High
Â¥1,284
Low
Â¥1,246
Mkt. cap
53.08B
Avg. vol.
199.47K
Volume
267.40K
Dividend
3.92%
Quarterly dividend
Â¥12
Ex-dividend date
Sep 29, 2025
P/E ratio
11.62
52-wk high
Â¥2,005
52-wk low
Â¥1,067
EPS
Â¥110
Shares outstanding
41.63M
No. of employees
2K
Open
Â¥1,255
High
Â¥1,284
Low
Â¥1,246
Mkt. cap
53.08B
Avg. vol.
199.47K
Volume
267.40K
Dividend
3.92%
Quarterly dividend
Â¥12
Ex-dividend date
Sep 29, 2025
P/E ratio
11.62
52-wk high
Â¥2,005
52-wk low
Â¥1,067
EPS
Â¥110
Shares outstanding
41.63M
No. of employees
2K
News stories
From sources across the web
About Shin Nippon Biomedical Laboratories Ltd
CEO-
Employees1.52K
Founded1957
Headquarters-
SectorHealth care
Websitesnbl.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.48B
8.29B
6.43B
11.33B
Cost of goods sold
3.41B
4.68B
2.20B
6.00B
Cost of revenue
3.41B
4.68B
2.20B
6.00B
Research and development expenses
-
-
-
2.40B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.41B
3.22B
3.25B
850.24M
Operating expense
3.41B
3.22B
3.25B
3.70B
Total operating expenses
6.82B
7.90B
5.45B
9.70B
Operating income
-340.94M
389.94M
978.59M
1.63B
Other non operating income
60.44M
54.56M
81.03M
107.77M
EBT including unusual items
333.50M
990.50M
1.43B
3.50B
EBT excluding unusual items
515.75M
1.11B
1.49B
2.71B
Income tax expense
77.00M
209.00M
229.77M
1.20B
Effective tax rate
23.09%
21.10%
16.11%
34.24%
Other operating expenses
-
-
-
-
Net income
260.42M
800.58M
1.21B
2.30B
Net profit margin
4.02%
9.66%
18.82%
20.26%
Earnings per share
-
-
-
-
Interest and investment income
7.68M
88.32M
14.12M
128.12M
Interest expense
-57.82M
-68.18M
-78.15M
-88.40M
Net interest expenses
-50.13M
20.13M
-64.03M
39.72M
Depreciation and amortization charges
-
-
-
411.00M
EBITDA
311.84M
1.17B
1.63B
2.48B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer